$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

$sgbx Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000121390022029275 Filed on May 24, 2022

Income Statement

Concept	2022 Q1	2021 Q4	2021 Q1
Revenue	$8.605M	$8.453M	$9.188M
YoY Change	-6.35%	15.0%	4522.57%
Cost Of Revenue	$6.118M	$10.28M	$8.631M
YoY Change	-29.11%	78.71%	5549.49%
Gross Profit	$2.486M	-$1.823M	$556.6K
YoY Change	346.7%	-213.25%	1110.55%
Gross Profit Margin	28.9%	-21.57%	6.06%
Selling, General & Admin	$923.4K	$347.5K	$880.4K
YoY Change	4.88%	-88.68%	10.05%
% of Gross Profit	37.14%		158.17%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$104.8K	$145.7K	$91.19K
YoY Change	14.95%	61.9%	9769.05%
% of Gross Profit	4.22%		16.38%
Operating Expenses	$2.068M	$347.5K	$1.718M
YoY Change	20.34%	-88.68%	115.99%
Operating Profit	$418.9K	-$2.171M	-$1.161M
YoY Change	-136.07%	48.68%	54.97%
Interest Expense	$48.85K	$15.70K	$363.00
YoY Change	13357.02%	-21.5%	-87.09%
% of Operating Profit	11.66%
Other Income/Expense, Net	$82.84K	$1.130K	$17.11K
YoY Change	384.22%		733.67%
Pretax Income	$501.7K	-$2.164M	-$1.144M
YoY Change	-143.84%	50.26%	53.11%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$717.2K	-$3.427M	-$2.034M
YoY Change	-64.74%	110.22%	172.12%
Net Earnings / Revenue	-8.33%	-40.54%	-22.14%
Basic Earnings Per Share	-$0.06
Diluted Earnings Per Share	-$59.77K	-$312.5K	-$232.3K
COMMON SHARES
Basic Shares Outstanding	12.00M shares	11.99M shares
Diluted Shares Outstanding	12.00M shares

Balance Sheet

Concept	2022 Q1	2021 Q4	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.15M	$13.02M	$10.54M
YoY Change	24.73%	0.11%	2535.0%
Cash & Equivalents	$13.15M	$13.02M	$10.54M
Short-Term Investments
Other Short-Term Assets	$7.592M	$3.200M	$22.90M
YoY Change	-66.85%	461.4%	30.86%
Inventory	$1.054M	$1.274M	$934.1K
Prepaid Expenses
Receivables	$2.425M	$2.918M	$3.217M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$21.94M	$17.91M	$17.84M
YoY Change	22.93%	-2.1%	980.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.081M	$6.840M	$3.454M
YoY Change	18.15%	154.94%	31812.72%
Goodwill	$1.309M	$1.309M	$1.309M
YoY Change	0.0%	0.0%	7.01%
Intangibles	$2.053M	$2.095M	$2.221M
YoY Change	-7.53%	-5.56%	-1.85%
Long-Term Investments	$4.300M	$3.800M
YoY Change
Other Assets	$102.0K	$112.2K	$140.0K
YoY Change	-27.17%	-25.23%	-22.22%
Total Long-Term Assets	$16.03M	$17.01M	$9.404M
YoY Change	70.43%	98.16%	130.2%
TOTAL ASSETS
Total Short-Term Assets	$21.94M	$17.91M	$17.84M
Total Long-Term Assets	$16.03M	$17.01M	$9.404M
Total Assets	$37.96M	$34.92M	$27.25M
YoY Change	39.32%	29.92%	374.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.476M	$3.785M	$6.020M
YoY Change	-9.04%	25.64%	244.0%
Accrued Expenses	$461.6K	$318.0K	$410.0K
YoY Change	12.58%	2.57%
Deferred Revenue	$5.206M	$1.438M	$1.133M
YoY Change	359.33%	-19.0%	726.0%
Short-Term Debt	$1.985M	$23.73K	$0.00
YoY Change
Long-Term Debt Due	$19.64K	$19.49K	$20.00K
YoY Change	-1.8%	-2.55%
Total Short-Term Liabilities	$13.15M	$11.59M	$7.813M
YoY Change	68.36%	60.15%	314.38%
LONG-TERM LIABILITIES
Long-Term Debt	$756.7K	$761.6K	$30.00K
YoY Change	2422.27%	2438.8%	-85.0%
Other Long-Term Liabilities	$2.420M	$860.5K	$1.130M
YoY Change	114.19%	-27.08%
Total Long-Term Liabilities	$3.177M	$1.622M	$1.160M
YoY Change	173.89%	34.06%	480.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.15M	$11.59M	$7.813M
Total Long-Term Liabilities	$3.177M	$1.622M	$1.160M
Total Liabilities	$16.33M	$13.21M	$8.965M
YoY Change	82.16%	56.42%	329.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$33.83M	-$33.11M	-$24.31M
YoY Change	39.14%	48.63%	32.62%
Common Stock	$120.1K	$119.9K	$88.21K
YoY Change	36.11%	39.44%	653.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$20.32M	$20.35M	$17.21M
YoY Change
Total Liabilities & Shareholders Equity	$37.96M	$34.92M	$27.25M
YoY Change	39.32%	29.92%	374.98%

Cashflow Statement

Concept	2022 Q1	2021 Q4	2021 Q1
OPERATING ACTIVITIES
Net Income	-$717.2K	-$3.427M	-$2.034M
YoY Change	-64.74%	110.22%	172.12%
Depreciation, Depletion And Amortization	$104.8K	$145.7K	$91.19K
YoY Change	14.95%	61.9%	9769.05%
Cash From Operating Activities	$3.257M	$369.7K	-$2.183M
YoY Change	-249.19%	-76.3%	112.61%
INVESTING ACTIVITIES
Capital Expenditures	$922.9K	-$648.9K	$862.1K
YoY Change	7.05%	-57.31%
Acquisitions
YoY Change
Other Investing Activities	-$599.2K	-$538.8K	-$90.00K
YoY Change	565.82%	498.67%	-77.5%
Cash From Investing Activities	-$1.861M	-$1.188M	-$990.4K
YoY Change	87.91%	-26.23%	147.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.274M	10.55M	$703.4K
YoY Change	-281.11%		251.93%
NET CHANGE
Cash From Operating Activities	$3.257M	369.7K	-$2.183M
Cash From Investing Activities	-$1.861M	-1.188M	-$990.4K
Cash From Financing Activities	-$1.274M	10.55M	$703.4K
Net Change In Cash	$122.0K	9.734M	-$2.470M
YoY Change	-104.94%	-19567.36%	101.32%
FREE CASH FLOW
Cash From Operating Activities	$3.257M	$369.7K	-$2.183M
Capital Expenditures	$922.9K	-$648.9K	$862.1K
Free Cash Flow	$2.334M	$1.019M	-$3.045M
YoY Change	-176.65%	-66.93%	196.57%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2095232	USD
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001023994
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	sgbx	License Agreement Automatically Renew Term LicenseAgreementAutomaticallyRenewTerm	P5Y
CY2022Q1	sgbx	License Agreement Initial Term LicenseAgreementInitialTerm	P5Y
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	SG BLOCKS, INC.
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4463937
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	5011 Gate Parkway,
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Building 100, Suite 100
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Jacksonville
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32256
CY2022Q1	dei	City Area Code CityAreaCode	(646)
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	240-4235
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2022Q1	dei	Trading Symbol TradingSymbol	SGBX
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12006873	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13146418	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13024381	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2424501	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2917646	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	41916	USD
CY2022Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4392541	USD
CY2021Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent		USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	1054342	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	1273825	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	784871	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	656279	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	21936068	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	17914047	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4080852	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6839943	USD
CY2022Q1	sgbx	Project Development Costs And Other Non Current Assets ProjectDevelopmentCostsAndOtherNonCurrentAssets	449961	USD
CY2021Q4	sgbx	Project Development Costs And Other Non Current Assets ProjectDevelopmentCostsAndOtherNonCurrentAssets	923172	USD
CY2022Q1	us-gaap	Goodwill Goodwill	1309330	USD
CY2021Q4	us-gaap	Goodwill Goodwill	1309330	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2902284	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1210053	USD
CY2022Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	829384	USD
CY2021Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	720137	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2053410	USD
CY2022Q1	us-gaap	Assets Assets	37963197	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1437579	USD
CY2022Q1	us-gaap	Deferred Costs DeferredCosts	101963	USD
CY2021Q4	us-gaap	Deferred Costs DeferredCosts	112159	USD
CY2022Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	700000	USD
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	200000	USD
CY2022Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3599945	USD
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3599945	USD
CY2021Q4	us-gaap	Assets Assets	34924018	USD
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5475882	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7568851	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5205712	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	481223	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	337469	USD
CY2022Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent		USD
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	264451	USD
CY2022Q1	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Current LiabilitiesOfBusinessTransferredUnderContractualArrangementCurrent	5795	USD
CY2021Q4	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Current LiabilitiesOfBusinessTransferredUnderContractualArrangementCurrent	5795	USD
CY2022Q1	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	1984902	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	13153514	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11586105	USD
CY2022Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	750000	USD
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	750000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2427080	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	872124	USD
CY2022Q1	us-gaap	Liabilities Liabilities	16330594	USD
CY2021Q4	us-gaap	Liabilities Liabilities	13208229	USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12006873	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12006873	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11986873	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11986873	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	120069	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	119869	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	54030291	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	53341405	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33826397	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33109220	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	20323963	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20352054	USD
CY2022Q1	us-gaap	Minority Interest MinorityInterest	1308640	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	1363735	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	6118163	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	8631002	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	2486435	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	556625	USD
CY2022Q1	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	1144187	USD
CY2021Q1	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	827522	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21715789	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37963197	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34924018	USD
CY2022Q1	us-gaap	Revenues Revenues	8604598	USD
CY2021Q1	us-gaap	Revenues Revenues	9187627	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21632603	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	780021	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	809800	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	143335	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	70627	USD
CY2022Q1	us-gaap	Pre Opening Costs PreOpeningCosts		USD
CY2021Q1	us-gaap	Pre Opening Costs PreOpeningCosts	10133	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2067543	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	1718082	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	418892	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1161457	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	48849	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	363	USD
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	12783	USD
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	17470	USD
CY2022Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	118902	USD
CY2021Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	82836	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	17107	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	501728	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1144350	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	501728	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-1144350	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1218905	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	889527	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-717177	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-2033877	USD
CY2022Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
CY2022Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	11998334	shares
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8744469	shares
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18437823	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	286186	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	703438	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-1144350	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18283097	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21715789	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	689086	USD
CY2022Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1274000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	501728	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21632603	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7024	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	501728	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-1144350	USD
CY2022Q1	us-gaap	Depreciation Depreciation	104825	USD
CY2021Q1	us-gaap	Depreciation Depreciation	91190	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	41823	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	40407	USD
CY2022Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	10196	USD
CY2021Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	10196	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	8628	USD
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	9247	USD
CY2021Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	9247	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	649090	USD
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-241	USD
CY2021Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-486117	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	581299	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	91479	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-219483	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	155935	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	679540	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-109308	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-97846	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2052971	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2062776	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	3768133	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-641412	USD
CY2022Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-264451	USD
CY2021Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-863151	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-102829	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-97342	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3257027	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2183116	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	922865	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	862090	USD
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		USD
CY2021Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	42500	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	760	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		USD
CY2022Q1	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	100000	USD
CY2021Q1	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		USD
CY2022Q1	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition		USD
CY2021Q1	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	85798	USD
CY2022Q1	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	338885	USD
CY2021Q1	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment		USD
CY2022Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	500000	USD
CY2021Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments		USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1860990	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-990388	USD
CY2022Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1274000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	122037	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2470066	USD
CY2021Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders		USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1274000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	703438	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13024381	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13010356	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13146418	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10540290	USD
CY2022Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		USD
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	703438	USD
CY2020Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-20
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12006873	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12006873	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13146418	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	7591863	USD
CY2021Q4	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	10488000	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: 'times new roman', times; font-size: 10pt;"> <div> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div> <div> <p style="color: #000000; font: 10pt 'Times New Roman', Times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0pt 0px 0pt 0.5in;"><span style="color: black;"><span style="border-left: none; border-right: none; line-height: inherit;"><span style="border-right: none; border-left: none; line-height: inherit;"><b><i>Accounting estimates<span style="line-height: inherit;"> </span></i></b>– The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Significant areas that require the Company to make estimates include revenue recognition, stock-based compensation, stock warrants liabilities and allowance for credit losses. Actual results could differ from those estimates.</span></span></span></p> </div> </div> </div> </div> </div> </div>
CY2022Q1	sgbx	No Of Operating Cycles NoOfOperatingCycles	one year
CY2022Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family: 'times new roman', times; font-size: 10pt;"> <div> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div> <div style="border-right: none; border-left: none;"> <div style="font-family: 'times new roman', times; font-size: 10pt;"> <div> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div> <p style="margin: 0pt 0pt 0pt 36pt; line-height: normal; font-size: 11pt; font-family: Calibri, 'sans-serif'; text-indent: 0pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><b><i><span>Reclassification – </span></i></b></span><span style="font-size: 9.0pt; font-family: 'Times New Roman','serif';"><span style="font-family: 'times new roman', times; font-size: 10pt;">Certain prior year balances were reclassed to conform to current period presentation.<span style="mso-spacerun: yes;"> </span>There was no impact to income (loss) or cash flows as a result of these reclassifications</span>.<span style="mso-spacerun: yes;"> </span></span><span style="font-family: 'Times New Roman', 'serif'; font-size: 9pt; text-indent: 0pt;"> </span></p> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div>
CY2022Q1	sgbx	Termofagreement Termofagreement	P2Y
CY2019Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.50	pure
CY2019Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	2500	shares
CY2021Q1	sgbx	Common Stock Vest And Be Issued Shares CommonStockVestAndBeIssuedShares	1250	shares
CY2021Q3	sgbx	Common Stock Remaining Vest And Be Issued Shares CommonStockRemainingVestAndBeIssuedShares	1250	shares
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalent Item Description RestrictedCashAndCashEquivalentItemDescription	the event that the Agreement was earlier terminated, CMC was entitled to receive the entire amount of such restricted stock that had vested as of such earlier termination date, but in no event less than 1,250 shares of such restricted stock. The Agreement also provided for customary indemnification and confidentiality obligations between the parties. The 2,500 shares of restricted stock of the Company's common stock has yet to be issued to CMC.
CY2022Q1	sgbx	Total Expected Gross Revenue TotalExpectedGrossRevenue	16900000	USD
CY2022Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	6885828	USD
CY2021Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	5863358	USD
CY2022Q1	sgbx	Revenue Recognized At Point In Time RevenueRecognizedAtPointInTime	6885828	USD
CY2022Q1	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	1718770	USD
CY2021Q1	sgbx	Revenue Recognized At Point In Time RevenueRecognizedAtPointInTime	5965413	USD
CY2021Q1	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	3222214	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8604598	USD
CY2022Q1	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9187627	USD
CY2021Q1	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2022Q1	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	306143	USD
CY2022Q1	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	102217	USD
CY2022Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	203926	USD
CY2022Q1	sgbx	Amortization Period Of Deferred Contract Costs AmortizationPeriodOfDeferredContractCosts	P60M
CY2022Q1	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	101963	USD
CY2022Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	10196	USD
CY2021Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	10196	USD
CY2022Q1	sgbx	License Consideration Description LicenseConsiderationDescription	In consideration for the License, during the initial term, the Licensee agreed to pay the Company a royalty of (x) five percent (5%) on the first $20,000,000 of gross revenues derived from the Licensee’s commercialization of the License (net of customary discounts, sales taxes, delivery charges, and amounts for returns) (the “Gross Revenues”), (y) four and one-half percent (4.5%) on the next $30,000,000 of Gross Revenues, and (z) five percent (5%) on all Gross Revenues thereafter (collectively, the “Royalty”)
CY2022Q1	sgbx	Minimum Royalty Payments One Year MinimumRoyaltyPaymentsOneYear	500000	USD
CY2022Q1	sgbx	Minimum Royalty Payments Two Year MinimumRoyaltyPaymentsTwoYear	750000	USD
CY2022Q1	sgbx	Minimum Royalty Payments Three Year MinimumRoyaltyPaymentsThreeYear	1500000	USD
CY2022Q1	sgbx	Minimum Royalty Payments Five Year MinimumRoyaltyPaymentsFiveYear	2500000	USD
CY2021Q2	sgbx	Redemption Distributions RedemptionDistributions	1.25	USD
CY2022Q1	sgbx	Minimum Royalty Payments Four Year MinimumRoyaltyPaymentsFourYear	2000000	USD
CY2020Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	200000	shares
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	502958	USD
CY2021	us-gaap	Other Income OtherIncome	60000	USD
CY2021Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	600000	USD
CY2021Q2	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.50	pure
CY2021Q2	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	350329	USD
CY2021Q2	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.10	pure
CY2021Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	3000000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13024381	USD
CY2021Q1	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	160469	USD
CY2022Q1	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	97164	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	857554	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	690262	USD
CY2022Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	121147	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	161176	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	157052	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	139716	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1313850	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2053410	USD
CY2021Q2	sgbx	Project Development Costs ProjectDevelopmentCosts	816410	USD
CY2021Q2	sgbx	Project Development Costs Book Value ProjectDevelopmentCostsBookValue	4392541	USD
CY2022Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin: 0pt 0pt 0pt 36pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Concentrations of credit risk </span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">–</span><span style="font-family: 'Times New Roman'; font-size: 10pt;"> Financial instruments, that potentially subject the Company to concentration of credit risk, consist principally of cash and cash equivalents. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limits. The Company has not experienced any losses in such account and believes that it is not exposed to any significant credit risk on the account. </span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">With respect to receivables, concentrations of credit risk are limited to a few customers in the construction industry. The Company performs ongoing credit evaluations of its customers’ financial condition and, generally, requires no collateral from its customers other than normal lien rights. At March 31, 2022 and December 31, 2021, 75% and 78%, respectively, of the Company’s gross accounts receivable were due from <span>two</span> and four customers. </span></p> <p style="margin: 0pt; text-indent: 36pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">Revenue relating to two and two customers represented approximately 90% and 80% of the Company's total revenue for the three months ended March 31, 2022 and 2021, respectively. </span></p> <p style="margin: 0pt; text-indent: 36pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><span>Cost of revenue relating to two and two vendors represented approximately 28% and 28% of the Company’s total cost of revenue for the three months ended March 31, 2022 and 2021, respectively. </span><span style="color: #000000; font-family: 'times new roman', times; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">The Company believes it has access to alternative suppliers, with limited disruption to the business, should circumstances change with its existing suppliers.</span></span></p>
CY2022Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3387617	USD
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3880762	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	963116	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	963116	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2424501	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2917646	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	963116	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	963116	USD
CY2022Q1	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	7004438	USD
CY2021Q4	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	4272425	USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7024	USD
CY2022Q1	sgbx	Provision For Loss On Uncompleted Contracts ProvisionForLossOnUncompletedContracts	391703	USD
CY2021Q4	sgbx	Provision For Loss On Uncompleted Contracts ProvisionForLossOnUncompletedContracts	2238578	USD
CY2022Q1	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	-3731057	USD
CY2021Q4	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	-3156377	USD
CY2022Q1	sgbx	Contract Assets Gross ContractAssetsGross	3665084	USD
CY2022Q1	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	8737401	USD
CY2021Q4	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	4750289	USD
CY2022Q1	sgbx	Netcontractliabilitiesonuncompletedcontracts Netcontractliabilitiesonuncompletedcontracts	-5072317	USD
CY2021Q4	sgbx	Netcontractliabilitiesonuncompletedcontracts Netcontractliabilitiesonuncompletedcontracts	-1395663	USD
CY2022Q1	sgbx	Contract With Customer Assets Net Current ContractWithCustomerAssetsNetCurrent	133395	USD
CY2021Q4	sgbx	Contract With Customer Assets Net Current ContractWithCustomerAssetsNetCurrent	41916	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5205712	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1437579	USD
CY2022Q1	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-5072317	USD
CY2021Q4	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-1395663	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4594437	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7249222	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	409279	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4080852	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6839943	USD
CY2022Q1	us-gaap	Depreciation Depreciation	104825	USD
CY2021Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2000000	USD
CY2021Q3	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	1948234	USD
CY2021Q3	us-gaap	Debt Instrument Term DebtInstrumentTerm	P1Y
CY2021Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.12	pure
CY2021Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.005	pure
CY2022Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	20000	USD
CY2021Q3	sgbx	Number Of Large Contracts Cancelled Partially NumberOfLargeContractsCancelledPartially	1	Number
CY2021Q3	sgbx	Cancellation Of Construction Backlog Contract Amountbacklogcontract CancellationOfConstructionBacklogContractAmountbacklogcontract	1300000	USD
CY2021Q4	sgbx	Number Of Large Contracts NumberOfLargeContracts	1	Number
CY2021Q4	sgbx	Construction Backlog Contract Revenue ConstructionBacklogContractRevenue	780000	USD
CY2021Q4	sgbx	Number Of Large Contracts Cancelled Partially NumberOfLargeContractsCancelledPartially	1	Number
CY2021Q4	sgbx	Cancellation Of Construction Backlog Contract Amountbacklogcontract CancellationOfConstructionBacklogContractAmountbacklogcontract	16900000	USD
CY2022Q1	sgbx	Construction Backlog Contract Revenue ConstructionBacklogContractRevenue	5954950	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	7591863	USD
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4314	USD
CY2021	sgbx	Short Term Debt Interest Charges ShortTermDebtInterestCharges	112348	USD
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	23727	USD
CY2021Q4	sgbx	Value Of Renovation Improvements ValueOfRenovationImprovements	750000	USD
CY2021Q4	sgbx	Principal Amount Of Promissory Note PrincipalAmountOfPromissoryNote	750000	USD
CY2022Q1	sgbx	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	2874936	USD
CY2022Q1	sgbx	Operating Lease Liabilities Current OperatingLeaseLiabilitiesCurrent	461584	USD
CY2022Q1	sgbx	Operating Lease Liabilities Noncurrent OperatingLeaseLiabilitiesNoncurrent	2420401	USD
CY2022Q1	sgbx	Totaloperatingleaseliabilities Totaloperatingleaseliabilities	-2881985	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	27348	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	19639	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6679	USD
CY2022Q1	sgbx	Totalfinanceleaseliabilities Totalfinanceleaseliabilities	-26318	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y4M24D
CY2022Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y4M9D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2022Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	405825	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	15120	USD
CY2022Q1	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	420945	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	525718	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	11760	USD
CY2022Q1	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	537478	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	523722	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree		USD
CY2022Q1	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	523722	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	446349	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour		USD
CY2022Q1	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	446349	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	207379	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive		USD
CY2022Q1	us-gaap	Other Commitment Due In Fifth Year OtherCommitmentDueInFifthYear	207379	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1119904	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive		USD
CY2022Q1	us-gaap	Other Commitment Due After Fifth Year OtherCommitmentDueAfterFifthYear	1119904	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3228897	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	26880	USD
CY2022Q1	us-gaap	Other Commitment OtherCommitment	3255777	USD
CY2022Q1	sgbx	Total Operating Imputed Interest TotalOperatingImputedInterest	346912	USD
CY2022Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	562	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	347474	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2881985	USD
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	26318	USD
CY2022Q1	sgbx	Presentvalueofleaseliabilities Presentvalueofleaseliabilities	2908303	USD
CY2022Q1	sgbx	Sublease Term SubleaseTerm	P1Y
CY2021Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	3217909	USD
CY2020Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	25117461	USD
CY2022Q1	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	6092724	USD
CY2021	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	3191335	USD
CY2021	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet	18297197	USD
CY2022Q1	sgbx	Construction Backlog Gross ConstructionBacklogGross	9310633	USD
CY2021	sgbx	Construction Backlog Gross ConstructionBacklogGross	10011599	USD
CY2022Q1	sgbx	Contract Revenue ContractRevenue	-1718770	USD
CY2021	sgbx	Contract Revenue ContractRevenue	6793690	USD
CY2022Q1	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	7591863	USD
CY2021Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	3217909	USD
CY2021	sgbx	Contract Backlog Description ContractBacklogDescription	two contracts entered into during the third quarter of 2020 in the amount of approximately $4 million and approximately $2.95 million
CY2021Q1	sgbx	Number Of Large Contracts NumberOfLargeContracts	1	Number
CY2021Q1	sgbx	Construction Backlog Contract Revenue ConstructionBacklogContractRevenue	1300000	USD
CY2021Q3	sgbx	Number Of Large Contracts NumberOfLargeContracts	1	Number
CY2021Q3	sgbx	Construction Backlog Contract Revenue ConstructionBacklogContractRevenue	870000	USD
CY2021Q4	sgbx	Gross Proceeds GrossProceeds	11550000	USD
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	10500000	USD
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2019Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	45000	shares
CY2019Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	17
CY2017Q2	sgbx	Warrants To Purchase WarrantsToPurchase	4313	shares
CY2017Q2	us-gaap	Share Price SharePrice	125
CY2017Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-06-21
CY2017Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	63796	USD
CY2020Q2	sgbx	Warrants To Purchase WarrantsToPurchase	300000	shares
CY2020Q2	us-gaap	Share Price SharePrice	3.14
CY2020Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2025-05-05
CY2021Q4	sgbx	Warrants To Purchase WarrantsToPurchase	1898630	shares
CY2021Q4	us-gaap	Share Price SharePrice	4.8
CY2021Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2016Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	25000	shares
CY2016Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3625000	shares
CY2022Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1343377	shares
CY2022Q1	sgbx	Stock Based Compensation Expens Total StockBasedCompensationExpensTotal	649090	USD
CY2021Q1	sgbx	Stock Based Compensation Expens Total StockBasedCompensationExpensTotal	286186	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36436	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	24.8
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	78.71
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y4M2D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022Q1	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
CY2022Q1	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageFairValue
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36436	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	24.8
CY2022Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	78.71
CY2022Q1	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P5Y1M2D
CY2022Q1	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value One ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueOne		USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	36436	shares
CY2021Q4	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue	24.8
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	78.71
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y4M2D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	36436	shares
CY2022Q1	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue	24.8
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	78.71
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y1M2D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized		USD
CY2022Q1	us-gaap	Share Price SharePrice	1.95
CY2019Q1	sgbx	Number Of Consultants NumberOfConsultants	1	Consultants
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	Restricted stock units granted to Mr. Galvin, Mr. Armstrong, Mr. Shetty, and an aggregate of six employees and one consultant of 6,139, 772, 5,729 and an aggregate of 3,063, respectively, vest in installments over either a one-year, two-year, three-year and four-year period and will fully vest by the end of December 31, 2022. The fair value of these units upon issuance amounted to $847,957.
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	a total of 526 of restricted stock units were granted to two of the Company’s non-employee directors, under the Incentive Plan, at the calculated fair value of $58.80 and $55.20 per share, respectively, which represents the average closing price of the Company’s common stock for the ten trading days immediately preceding and including the grant date as adjusted for stock splits.
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	a total of 526 of restricted stock units were granted to two of the Company’s non-employee directors, under the Incentive Plan, at the calculated fair value of $58.80 and $55.20 per share, respectively, which represents the average closing price of the Company’s common stock for the ten trading days immediately preceding and including the grant date as adjusted for stock splits.
CY2019Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	9189	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.4
CY2022Q1	sgbx	Options Vested Description OptionsVestedDescription	the Company’s common stock for the ten trading days immediately preceding and including the grant date. Restricted stock units granted to directors on June 5, 2019 vest on the earlier of (A) the first anniversary of the date of the grant or (B) the date of the annual meeting of the Company’s stockholders that occurs in the year immediately following the date of the grant; and are payable six months after the termination of the director from the Board or death or disability.
CY2020Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	425000	shares
CY2020Q3	sgbx	Number Of Consultants NumberOfConsultants	1	Consultants
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.81
CY2020Q3	sgbx	Options Vested Description OptionsVestedDescription	the Company's common stock on September 23, 2020. Restricted stock units granted to Mr. Armstrong, Mr. Sheeran, and an aggregate of seven employees and one consultant of 50,000, 75,000 and an aggregate of 300,000, respectively, and 1/3 will vest on September 23, 2020, 1/3 on the one year anniversary of the grant date and 1/3 on the two year anniversary of the grant date. The fair value of these units upon issuance amounted to $769,250.
CY2021Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	1214500	shares
CY2021Q4	us-gaap	Share Price SharePrice	3.38
CY2021Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	475000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1274137	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	212999	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	17500	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1043638	shares
CY2019Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2100000	USD
CY2018Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	761401.66	USD
CY2020Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2861401.66	USD
CY2019Q2	sgbx	Unpaid Wages UnpaidWages	30428.71	USD
CY2021Q3	sgbx	Recovery Of Damages Sought RecoveryOfDamagesSought	67125.83	USD
CY2020Q1	sgbx	Unpaid Wages UnpaidWages	372638	USD
CY2020Q1	sgbx	Severance Amount SeveranceAmount	300000	USD
CY2020Q2	sgbx	Severance Amount SeveranceAmount	300000	USD
CY2021Q2	us-gaap	Unrecorded Unconditional Purchase Obligation Period Quantity Purchased UnrecordedUnconditionalPurchaseObligationPeriodQuantityPurchased	2000000	shares
CY2021Q2	us-gaap	Other Commitments Description OtherCommitmentsDescription	provide for an annual base salary of $400,000 provide for a performance bonus structure for a bonus of up to 50% of base salary upon the Company’s achievement of $2,000,000 EBITDA and additional performance bonus payments for the achievement of EBITDA in excess of $2,000,000 based on a percentage of the incremental increase in EBITDA (ranging from 10% of the incremental increase in EBITDA if the Company achieves over $2,000,000 and up to $7,000,000 in EBITDA, 8% of the incremental increase in EBITDA if the Company achieves over $7,000,000 and up to $12,000,000 in EBITDA and 3% of the incremental increase in EBITDA over $12,000,000), provide for a profits-based additional bonus of up to $250,000 in certain limited circumstances, and provide for one (1) year severance, plus a pro-rated amount of any unpaid bonus earned by him during the year as verified by the Company’s principal financial officer, if Mr. Galvin is terminated without cause. At the Company’s option, up to fifty (50%) percent of the EBITDA performance bonuses may be paid in restricted stock units if then available for grant under the Company’s Stock Incentive Plan.All other terms of the employment agreement remain in full force and effect.

Files In Submission

Name	View Source	Status
0001213900-22-029275-index-headers.html	Edgar Link	pending
0001213900-22-029275-index.html	Edgar Link	pending
0001213900-22-029275.txt	Edgar Link	pending
0001213900-22-029275-xbrl.zip	Edgar Link	pending
ex311_1.htm	Edgar Link	pending
ex321_2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgbx-20220331.htm	Edgar Link	pending
sgbx-20220331.xsd	Edgar Link	pending
sgbx-20220331_cal.xml	Edgar Link	unprocessable
sgbx-20220331_def.xml	Edgar Link	unprocessable
sgbx-20220331_htm.xml	Edgar Link	completed
sgbx-20220331_lab.xml	Edgar Link	unprocessable
sgbx-20220331_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2022 Q1 Form 10-Q Financial Statement

#000121390022029275 Filed on May 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2022 Q1 Form 10-Q Financial Statement

#000121390022029275 Filed on May 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx